Hercules Capital Aktie News

I'm maintaining a "Buy" rating on Hercules Capital as I believe there are seven key reasons why it remains the top pick in the BDC sector for 2026. HTGC's business model is well adapted to the rate-cutting cycle, demonstrating effective scaling through its internal management structure and a clear commitment to diversifying cash flows. HTGC's dividend yield is expected to remain stable, while t...

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-...

Most BDCs are exposed to a SOFR-driven dividend normalization process. Yet, Hercules Capital stands out as a rare high-quality exception, which has the necessary tools to preserve its base dividend. In the article I share more details about the underlying fundamentals and specific market dynamics that create a solid case for accessing reliable income from HTGC.

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), strengthening its balance sheet and liquidity. Under the terms of the amended loan agreement, up to an additional $75 million will beco...

Business development companies offer high yields, but investors must be wary of yield traps and underlying credit risks. Premium BDCs like Main Street Capital, Hercules Capital, and Capital Southwest justify higher valuations with strong management, healthy portfolios, and resilient dividends. Recent outflows and dividend cuts reflect investor disappointment with falling rates, but top-tier BDC...

Hercules Capital is rated a buy, supported by robust dividend coverage and record originations as the Fed cuts rates. HTGC maintains a 10% dividend yield, with 104% coverage of the aggregate dividend and 122% coverage of the base dividend. Portfolio growth is strong, with total investments up 17.8% year-to-date, with AUM up 20.7% over its year-ago comp.

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that it has entered into an amendment to an amended and restated loan and security agreement (as amended, the “Loan Agreement”) with two of its subsidiaries and Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”), as agent, for u...

The market is pricing in a crisis that the data simply does not show. A misunderstood corner of credit is flashing rare value signals. The disconnect between headlines and fundamentals is growing fast.